Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Biagio Mercuri

Showing results (1-10 of 276) with videos related to

Pageof 28
Sort By:
Trends in Pharmacological Sciences|June 7, 2005
The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?Nicola Biagio Mercuri, Giorgio Bernardi
Frontiers in Molecular Neuroscience|October 18, 2018
mGluR1-Dependent Long Term Depression in Rodent Midbrain Dopamine Neurons Is Regulated by Neuregulin 1/ErbB SignalingAda Ledonne, Nicola Biagio Mercuri
Journal of Clinical Medicine|March 10, 2022
Could the New Anti-CGRP Monoclonal Antibodies Be Effective in Migraine Aura? Case Reports and Literature ReviewMaria Albanese, Nicola Biagio Mercuri
British Journal of Pharmacology|February 23, 2012
Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemiaMarta Armogida, Robert Nisticò, Nicola Biagio Mercuri
Drugs|October 4, 2024
Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep DisordersMatteo Carpi, Nicola Biagio Mercuri, Claudio Liguori
International Journal of Molecular Sciences|January 11, 2025
Exceeding the Limits with Nutraceuticals: Looking Towards Parkinson's Disease and FrailtyMartina Montanari, Nicola Biagio Mercuri, Giuseppina Martella
International Journal of Molecular Sciences|January 20, 2021
Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and PlasticityRachel Price, Nicola Biagio Mercuri, Ada Ledonne
Neuroscience|March 7, 2018
3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT InhibitionFrancesca Romana Rizzo, Mauro Federici, Nicola Biagio Mercuri
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 28, 2019
Rhythmic auditory stimulation in gait rehabilitation for traumatic brain and spinal cord injuryAnas R Alashram, Giuseppe Annino, Nicola Biagio Mercuri
The Journal of Spinal Cord Medicine|May 15, 2020
Changes in spasticity following functional electrical stimulation cycling in patients with spinal cord injury: A systematic reviewAnas R Alashram, Giuseppe Annino, Nicola Biagio Mercuri
Pageof 28

Showing results (1-10 of 276) with videos related to

Sort By:
Pageof 28
Trends in Pharmacological Sciences|June 7, 2005
The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?Nicola Biagio Mercuri, Giorgio Bernardi
Frontiers in Molecular Neuroscience|October 18, 2018
mGluR1-Dependent Long Term Depression in Rodent Midbrain Dopamine Neurons Is Regulated by Neuregulin 1/ErbB SignalingAda Ledonne, Nicola Biagio Mercuri
Journal of Clinical Medicine|March 10, 2022
Could the New Anti-CGRP Monoclonal Antibodies Be Effective in Migraine Aura? Case Reports and Literature ReviewMaria Albanese, Nicola Biagio Mercuri
British Journal of Pharmacology|February 23, 2012
Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemiaMarta Armogida, Robert Nisticò, Nicola Biagio Mercuri
Drugs|October 4, 2024
Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep DisordersMatteo Carpi, Nicola Biagio Mercuri, Claudio Liguori
International Journal of Molecular Sciences|January 11, 2025
Exceeding the Limits with Nutraceuticals: Looking Towards Parkinson's Disease and FrailtyMartina Montanari, Nicola Biagio Mercuri, Giuseppina Martella
International Journal of Molecular Sciences|January 20, 2021
Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and PlasticityRachel Price, Nicola Biagio Mercuri, Ada Ledonne
Neuroscience|March 7, 2018
3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT InhibitionFrancesca Romana Rizzo, Mauro Federici, Nicola Biagio Mercuri
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 28, 2019
Rhythmic auditory stimulation in gait rehabilitation for traumatic brain and spinal cord injuryAnas R Alashram, Giuseppe Annino, Nicola Biagio Mercuri
The Journal of Spinal Cord Medicine|May 15, 2020
Changes in spasticity following functional electrical stimulation cycling in patients with spinal cord injury: A systematic reviewAnas R Alashram, Giuseppe Annino, Nicola Biagio Mercuri
Pageof 28